BIG
MRVI icon

Brooklyn Investment Group’s Maravai LifeSciences MRVI Stock Holding History

Brooklyn Investment Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96.1K Sell
33,969
-6,470
-16% -$21.9K ﹤0.01% 1797
2025
Q4 		$135K Sell
40,439
-95,888
-70% -$323K 0.01% 1435
2025
Q3 		$337K Sell
136,327
-2,179
-2% -$5.56K 0.05% 386
2025
Q2 		$334K Buy
+138,506
New +$291K 0.04% 402
2024
Q4 		– Sell
-129
Closed -$1.07K – 1949
2024
Q3 		$1.07K Buy
+129
New +$1.11K ﹤0.01% 957

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brooklyn Investment Group's MRVI Position: Q1 2026 in Review

Brooklyn Investment Group reduced its Maravai LifeSciences (MRVI) stake by 16% in Q1 2026, selling an estimated $21.9K and leaving 33,969 shares worth $96.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1797.

Brooklyn Investment Group first reported a position in MRVI in Q3 2024 and has held it in 5 quarters since. The position peaked at $337K in Q3 2025. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Brooklyn Investment Group held 33,969 shares of Maravai LifeSciences worth $96.1K as of Q1 2026.
  • Brooklyn Investment Group sold 6,470 Maravai LifeSciences shares in Q1 2026, an estimated $21.9K.
  • Maravai LifeSciences made up ﹤0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1797 holding.
  • Brooklyn Investment Group first reported a position in Maravai LifeSciences in Q3 2024 and has held it in 5 quarters since.
  • Brooklyn Investment Group's Maravai LifeSciences position peaked at $337K in Q3 2025.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.